IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Design, Development and Evaluation of Oral Sustained Release In-Situ Floating Gel as A Carrier for Stomach Specific Delivery of Anti Ulcer Drug.

Author: VIJAYSINH SABLE, MAHESH K. GUPTA, NEETESH K. JAIN, GURDEEP SINGH
Abstract: Gastroretentive drug delivery is one of the targeted strategy for prolonging gastric residence time, in management of peptic ulcer along with optimizing site-specific drug release for local or systemic impact in the upper gastrointestinal tract (GIT). Many gastroretentive drug delivery methods have been designed and developed over the last few decades. In present research, we have developed oral sustained release in-situ floating gel as a carrier for stomach specific delivery of anti Nizatidine (NZD). NZD is an antagonist of histamine H2-receptor. It is used commonly in severe duodenal ulcers, stomach ulcers, ulcerative esophagitis, heartburn. Nevertheless, the recent failure of proton pump inhibitors to suppress nighttime gastric acid spike (related to high nocturnal histamine concentration) and side effects from other H2-receptor antagonists (gyanacomastia) open a new path to NZD delivery at specific times in relation to symptom onset. Around 10 batches (F1-F10) were formulated and were subjected to determination of f2 value, viscosity (cps), gel strength (dyne/cm2), pH, drug content and in-vivo pharmacokinetic study. In-vivo investigations demonstrated that there was a marked difference in the reduction of ulcer index and volume of gastric acid secretion from nizatidine in situ gelling formulation (for optimized batch F6) when compared with the plain nizatidine solution (P < 0.01) and control group (P < 0.001). So, an effective oral sustained release in-situ floating gel as a carrier for stomach specific delivery of anti Nizatidine were formulated and evaluated successfully.
Keyword: Nizatidine, Oral Sustained Release, In-Situ Floating Gel, Stomach Specific Delivery.
DOI: https://doi.org/10.31838/ijpr/2020.12.03.132
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free